![]() |
市場調査レポート
商品コード
1663058
神経デバイス市場規模、シェア、成長分析:製品タイプ別、エンドユーザー別、地域別 - 産業予測 2025~2032年Neurology Devices Market Size, Share, and Growth Analysis, By Product Type (Neurostimulation, Interventional Neurology), By End User (Hospitals, Ambulatory Surgery Centers), By Region - Industry Forecast 2025-2032 |
||||||
|
神経デバイス市場規模、シェア、成長分析:製品タイプ別、エンドユーザー別、地域別 - 産業予測 2025~2032年 |
出版日: 2025年02月21日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
神経デバイスの世界市場規模は2023年に157億6,000万米ドルとなり、予測期間(2025-2032年)のCAGRは8.1%で、2024年の170億4,000万米ドルから2032年には317億7,000万米ドルに成長する見通しです。
神経デバイス市場は、神経疾患の有病率の上昇、民間投資の増加、神経治療の研究開発の進展に牽引され、力強い成長を遂げています。国連人口基金は、65歳以上の世界人口がほぼ倍増すると予測しており、特にアルツハイマー病、脳卒中、パーキンソン病などの疾患に対する高度な診断・治療機器への需要が高まっていることを浮き彫りにしています。加えて、高齢化社会における神経血管障害の急増は、低侵襲手術の人気の高まりと相まって、市場の需要をさらに押し上げています。しかし、急性虚血性脳卒中の世界の発生率の増加によってもたらされる好機にもかかわらず、高額な機器コスト、厳しい規制、新興国市場でのアクセス制限などの課題が、長期的には市場拡大の妨げになる可能性があります。
Global Neurology Devices Market size was valued at USD 15.76 billion in 2023 and is poised to grow from USD 17.04 billion in 2024 to USD 31.77 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).
The neurology devices market is experiencing robust growth, driven by the rising prevalence of neurological disorders, increased private sector investment, and advancements in neurotherapy research and development. The United Nations Population Fund projects that the global population aged over sixty-five will nearly double, highlighting the escalating demand for sophisticated diagnostic and therapeutic devices, particularly for conditions such as Alzheimer's, stroke, and Parkinson's disease. Additionally, the surge in neurovascular disorders amid an aging demographic, combined with the growing popularity of minimally invasive procedures, is further propelling market demand. However, challenges such as high device costs, stringent regulations, and limited accessibility in developing regions may hinder market expansion in the long term, despite the flourishing opportunities presented by the increasing incidence of acute ischemic strokes globally.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Neurology Devices Market Segments Analysis
Global Neurology Devices Market is segmented by Product Type, End User and region. Based on Product Type, the market is segmented into Neurostimulation, Interventional Neurology, CSF Management Devices and Neurosurgery Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Neurology Devices Market
The global neurology devices market is driven by a combination of unhealthy lifestyle choices and rising incidences of neurovascular diseases, such as strokes and cerebral aneurysms. These factors have led to an increased demand for neurovascular devices, essential for treating these conditions. Additionally, the aging population worldwide significantly contributes to this demand, as elderly individuals are more susceptible to neurological and neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and various forms of dementia. This demographic trend is particularly pronounced in regions like North America, Europe, and parts of Asia, which are experiencing heightened pressure on their healthcare systems to provide effective diagnostic, medical, and neurological interventions.
Restraints in the Global Neurology Devices Market
The Global Neurology Devices market faces significant constraints primarily due to the high costs associated with neurovascular devices, which leverage advanced medical technologies. While developed nations may absorb these expenses, healthcare facilities in developing countries often operate under tight budgets, hindering their access to such devices. Additionally, there is a notable shortage of specialized training for healthcare professionals to effectively use these advanced tools and accurately interpret their results, particularly in underserved regions. This situation underscores the pressing need for more affordable neurology solutions and comprehensive training programs to improve accessibility and utilization of these critical devices.
Market Trends of the Global Neurology Devices Market
The Global Neurology Devices market is witnessing a significant trend towards advancements in neurostimulation technology, which is revolutionizing the treatment landscape for neurological disorders. Devices such as deep brain stimulators (DBS) and spinal cord stimulators (SCS) are gaining traction for their efficacy in managing chronic pain, epilepsy, Parkinson's disease, and dementia. These innovative neurostimulation solutions emphasize precision and connectivity, enhancing patient outcomes while minimizing invasiveness. Additionally, improvements in battery life and user-friendly interfaces are further driving adoption among healthcare professionals and patients alike. This trend points to a growing preference for more sophisticated, effective, and less invasive therapy options in neurology.